From a clinical perspective, we found that MCAM, ADAM17, and NOX1 mRNA expressions are increased in the angiogenic, aggressive CMS4 subtype of CRC and that MCAM expression correlates with pro-angiogenic and pro-lymphangiogenic factors. The gene discussed is ADAM17; the disease is colorectal carcinoma.